News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
680,302 Results
Type
Article (56706)
Company Profile (301)
Press Release (623282)
Multimedia
Podcasts (135)
Webinars (26)
Section
Business (180480)
Career Advice (2603)
Deals (33135)
Drug Delivery (132)
Drug Development (85695)
Employer Resources (174)
FDA (17048)
Job Trends (14246)
News (324770)
Policy (33764)
Tag
Academia (2769)
Academic (1)
Accelerated approval (18)
Adcomms (35)
Allergies (121)
Alliances (47627)
ALS (145)
Alzheimer's disease (1679)
Antibody-drug conjugate (ADC) (222)
Approvals (17063)
Artificial intelligence (438)
Autoimmune disease (71)
Automation (24)
Bankruptcy (341)
Best Places to Work (11121)
BIOSECURE Act (23)
Biosimilars (157)
Biotechnology (202)
Bladder cancer (124)
Brain cancer (49)
Breast cancer (469)
Cancer (3785)
Cardiovascular disease (338)
Career advice (2191)
Career pathing (38)
CAR-T (239)
CDC (57)
Cell therapy (649)
Cervical cancer (32)
Clinical research (71179)
Collaboration (1338)
Company closure (4)
Compensation (917)
Complete response letters (59)
COVID-19 (2910)
CRISPR (77)
C-suite (558)
Cystic fibrosis (133)
Data (4319)
Decentralized trials (2)
Denatured (38)
Depression (107)
Diabetes (442)
Diagnostics (6656)
Digital health (34)
Diversity (10)
Diversity, equity & inclusion (47)
Drug discovery (197)
Drug pricing (186)
Drug shortages (35)
Duchenne muscular dystrophy (203)
Earnings (71997)
Editorial (54)
Employer branding (20)
Employer resources (153)
Events (103522)
Executive appointments (938)
FDA (19448)
Fibrodysplasia Ossificans Progressiva (3)
Friedreich's ataxia (6)
Frontotemporal dementia (14)
Funding (1198)
Gene editing (168)
Generative AI (35)
Gene therapy (529)
GLP-1 (1000)
Government (4853)
Grass and pollen (7)
Guidances (335)
Healthcare (18337)
HIV (46)
Huntington's disease (37)
IgA nephropathy (56)
Immunology and inflammation (239)
Immuno-oncology (20)
Indications (53)
Infectious disease (3143)
Inflammatory bowel disease (186)
Inflation Reduction Act (13)
Influenza (93)
Intellectual property (187)
Interviews (485)
IPO (16511)
IRA (56)
Job creations (3528)
Job search strategy (1810)
Kidney cancer (14)
Labor market (71)
Layoffs (621)
Leadership (33)
Legal (7688)
Liver cancer (90)
Longevity (11)
Lung cancer (544)
Lymphoma (264)
Machine learning (28)
Management (58)
Manufacturing (593)
MASH (137)
Medical device (13178)
Medtech (13198)
Mergers & acquisitions (17501)
Metabolic disorders (1128)
Multiple sclerosis (137)
NASH (23)
Neurodegenerative disease (225)
Neuropsychiatric disorders (59)
Neuroscience (2698)
NextGen: Class of 2025 (6295)
Non-profit (4536)
Now hiring (44)
Obesity (550)
Opinion (283)
Ovarian cancer (126)
Pain (161)
Pancreatic cancer (166)
Parkinson's disease (241)
Partnered (25)
Patents (405)
Patient recruitment (304)
Peanut (56)
People (53680)
Pharmaceutical (71)
Pharmacy benefit managers (27)
Phase I (22018)
Phase II (31085)
Phase III (23540)
Pipeline (2671)
Policy (289)
Postmarket research (2896)
Preclinical (9483)
Press Release (50)
Prostate cancer (195)
Psychedelics (52)
Radiopharmaceuticals (258)
Rare diseases (665)
Real estate (5254)
Recruiting (68)
Regulatory (24745)
Reports (51)
Research institute (2552)
Resumes & cover letters (428)
Rett syndrome (16)
RNA editing (15)
RSV (69)
Schizophrenia (132)
Series A (203)
Series B (153)
Service/supplier (12)
Sickle cell disease (79)
Special edition (25)
Spinal muscular atrophy (166)
Sponsored (39)
Startups (3495)
State (1)
Stomach cancer (17)
Supply chain (97)
Tariffs (95)
The Weekly (96)
Vaccines (1030)
Venture capital (66)
Weight loss (389)
Women's health (56)
Worklife (21)
Date
Last 7 days (537)
Last 30 days (2150)
Last 365 days (31473)
2025 (24762)
2024 (35790)
2023 (40258)
2022 (51466)
2021 (55608)
2020 (53581)
2019 (44924)
2018 (33943)
2017 (33081)
2016 (32247)
2015 (36562)
2014 (29471)
2013 (24446)
2012 (25772)
2011 (26247)
2010 (24458)
Location
Africa (873)
Alabama (73)
Alaska (6)
Arizona (228)
Arkansas (14)
Asia (40546)
Australia (7019)
California (9051)
Canada (2638)
China (854)
Colorado (373)
Connecticut (407)
Delaware (253)
Europe (95296)
Florida (1352)
Georgia (287)
Hawaii (3)
Idaho (61)
Illinois (687)
India (44)
Indiana (430)
Iowa (18)
Japan (308)
Kansas (113)
Kentucky (34)
Louisiana (19)
Maine (73)
Maryland (1224)
Massachusetts (6732)
Michigan (260)
Minnesota (522)
Mississippi (4)
Missouri (104)
Montana (28)
Nebraska (24)
Nevada (98)
New Hampshire (69)
New Jersey (2518)
New Mexico (28)
New York (2468)
North Carolina (1289)
North Dakota (10)
Northern California (4153)
Ohio (274)
Oklahoma (17)
Oregon (41)
Pennsylvania (1860)
Puerto Rico (17)
Rhode Island (39)
South America (1221)
South Carolina (48)
South Dakota (1)
Southern California (3492)
Tennessee (137)
Texas (1386)
United States (32951)
Utah (261)
Virginia (232)
Washington D.C. (73)
Washington State (761)
West Virginia (4)
Wisconsin (84)
Wyoming (1)
680,302 Results for "alzheimer s disease data initiative".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Annovis Announces Novel Biomarker Data in Alzheimer’s Patients Supporting Buntanetap’s Potential as a Disease-Modifying Treatment
October 10, 2025
·
3 min read
Alzheimer’s disease
5 Alzheimer’s Readouts To Watch
These five upcoming data drops could usher in more effective and convenient therapies for Alzheimer’s disease and open up novel pathways of action to treat the memory-robbing illness.
July 28, 2025
·
8 min read
·
Tristan Manalac
Alzheimer’s disease
Biogen, Eisai’s Leqembi Slows Alzheimer’s Progression Through 4 Years of Treatment
Long-term data presented at the Alzheimer’s Association International Conference show Leqembi can help patients stay in the earlier stages of Alzheimer’s disease as compared to the condition’s natural progression.
July 30, 2025
·
2 min read
·
Tristan Manalac
Alzheimer’s disease
Roche, Lilly Win First FDA Nod for Alzheimer’s Blood Test for Primary Care Use
Elecsys’ approval could help boost the uptake of currently approved Alzheimer’s disease therapies, including Biogen’s Eisai-partnered Leqembi, with CEO Chris Viehbacher recently noting that such biomarker-based tests could “remove some of the bottlenecks” in uptake.
October 14, 2025
·
2 min read
·
Tristan Manalac
Press Releases
IGC Pharma Announces Preclinical Data Demonstrating TGR-63’s Dual Action on Alzheimer’s Pathology
September 25, 2025
·
3 min read
Press Releases
LEQEMBI® (Lecanemab) Approved for the Treatment of Alzheimer’s Disease in Australia
September 25, 2025
·
14 min read
Press Releases
Alamar Biosciences, Alzheimer’s Disease Data Initiative, and Gates Ventures Unite in Global Partnership to Advance Translational Research in Alzheimer’s Disease.
June 11, 2025
·
3 min read
Press Releases
Neurogen Biomarking to present novel data on at-home p-tau 217 testing for Alzheimer’s disease at Alzheimer’s Association International Conference® 2025
July 17, 2025
·
1 min read
Press Releases
Arrowhead Pharmaceuticals Requests Regulatory Clearance to Initiate Phase 1/2a Study of ARO-MAPT for the Treatment of Alzheimer’s Disease and Other Tauopathies
September 10, 2025
·
7 min read
Press Releases
“LEQEMBI®” (lecanemab) IV Maintenance Dosing for the Treatment of Early Alzheimer’s Disease Approved in China
September 28, 2025
·
12 min read
1 of 68,031
Next
